Other reports also implicated some of the RhoGTPases in drug resistance60, thus it will be interesting in future studies to further investigate whether TGFβ/EPHA4 signaling could also modulate resistance to chemotherapy treatments in breast cancer patients. This evidence concerns the gene TGFB1 and breast carcinoma.